Molecular beacon-based real-time PCR method for detection of 15 high-risk and 5 low-risk HPV types

Journal of Virological Methods

Volumn 149, Issue 1, 2008, Pages 153-162

  Takács, Tibor ^a   Jeney, Csaba ^a,b   Kovács, Laura ^a   Mózes, Johanna ^a   Benczik, Márta ^a   Sebe, Attila ^b  

^a Genoid Ltd   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

HPV detection; Molecular beacon; Multiplex real time PCR

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; MOLECULAR BEACON; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; BASE SEQUENCE; FEMALE; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT;

HUMAN PAPILLOMAVIRUS;

EID: 40849094132     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.12.009     Document Type: Article

References (29)

1. Arbyn M., Paraskevaidis E., Martin-Hirsch P., Prendiville W., and Dillner J. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol. Oncol. 99 (2005) S7-S11
2. Cuzick J., Clavel C., Petry K.U., Meijer C.J., Hoyer H., Ratnam S., Szarewski A., Birembaut P., Kulasingam S., Sasieni P., and Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int. J. Cancer 119 (2006) 1095-1101
3. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and zur Hausen H. Classification of papillomaviruses. Virology 324 (2004) 17-27
4. Gravitt P.E., Peyton C., Wheeler C., Apple R., Higuchi R., and Shah K.V. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J. Virol. Methods 112 (2003) 23-33
5. Hart K.W., Williams O.M., Thelwell N., Fiander A.N., Brown T., Borysiewicz L.K., and Gelder C.M. Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples. J. Clin. Microbiol. 39 (2001) 3204-3212
6. Heid C.A., Stevens J., Livak K.J., and Williams P.M. Real time quantitative PCR. Genome Res. 6 (1996) 986-994
7. Hubbard R.A. Human papillomavirus testing methods. Arch. Pathol. Lab. Med. 127 (2003) 940-945
8. James D. A simple and reliable protocol for the detection of apple stem grooving virus by RT-PCR and in a multiplex PCR assay. J. Virol. Methods 83 (1999) 1-9
9. Jeney C., Takacs T., Sebe A., and Schaff Z. Detection and typing of 46 genital human papillomaviruses by the L1F/L1R primer system based multiplex PCR and hybridization. J. Virol. Methods 140 (2007) 32-42
10. Jordens J.Z., Lanham S., Pickett M.A., Amarasekara S., Abeywickrema I., and Watt P.J. Amplification with molecular beacon primers and reverse line blotting for the detection and typing of human papillomaviruses. J. Virol. Methods 89 (2000) 29-37
11. Kjaer S.K., van den Brule A.J., Paull G., Svare E.I., Sherman M.E., Thomsen B.L., Suntum M., Bock J.E., Poll P.A., and Meijer C.J. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325 (2002) 572
12. Koliopoulos G., Arbyn M., Martin-Hirsch P., Kyrgiou M., Prendiville W., and Paraskevaidis E. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol. Oncol. 104 (2007) 232-246
13. Mayrand M.H., Duarte-Franco E., Rodrigues I., Walter S.D., Hanley J., Ferenczy A., Ratnam S., Coutlée F., Franco E.L., and Canadian Cervical Cancer Screening Trial Study Group. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N. Engl. J. Med. 357 (2007) 1579-1588
14. Moberg M., Gustavsson I., and Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J. Clin. Microbiol. 41 (2003) 3221-3228
15. Molden T., Kraus I., Skomedal H., Nordstrom T., and Karlsen F. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. J. Virol. Methods 142 (2007) 204-212
16. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., Meijer C.J., and International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 (2003) 518-527
17. Naucler P., Ryd W., Törnberg S., Strand A., Wadell G., Elfgren K., Rådberg T., Strander B., Forslund O., Hansson B.G., Rylander E., and Dillner J. Human papillomavirus and papanicolaou tests to screen for cervical cancer. N. Engl. J. Med. 357 (2007) 1589-1597
18. Olcese V.A., Chen Y., Schlegel R., and Yuan H. Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope. BMC Microbiol. 4 (2004) 29
19. Ralser M., Querfurth R., Warnatz H.J., Lehrach H., Yaspo M.L., and Krobitsch S. An efficient and economic enhancer mix for PCR. Biochem. Biophys. Res. Commun. 347 (2006) 747-751
20. Roberts R.W., and Crothers D.M. Specificity and stringency in DNA triplex formation. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 9397-9401
21. Szuhai K., Sandhaus E., Kolkman-Uljee S.M., Lemaitre M., Truffert J.C., Dirks R.W., Tanke H.J., Fleuren G.J., Schuuring E., and Raap A.K. A novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon polymerase chain reaction. Am. J. Pathol. 159 (2001) 1651-1660
22. Tapp I., Malmberg L., Rennel E., Wik M., and Syvanen A.C. Homogeneous scoring of single-nucleotide polymorphisms: comparison of the 5′-nuclease TaqMan assay and molecular beacon probes. Biotechniques 28 (2000) 732-738
23. Tsourkas A., Behlke M.A., Rose S.D., and Bao G. Hybridization kinetics and thermodynamics of molecular beacons. Nucleic Acids Res. 31 (2003) 1319-1330
24. Tucker R.A., Unger E.R., Holloway B.P., and Swan D.C. Real-time PCR-based fluorescent assay for quantitation of human papillomavirus types 6, 11, 16, and 18. Mol. Diagn. 6 (2001) 39-47
25. Tyagi S., and Kramer F.R. Molecular beacons: probes that fluoresce upon hybridization. Nat. Biotechnol. 14 (1996) 303-308
26. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
27. Wang L., Blasic Jr. J.R., Holden M.J., and Pires R. Sensitivity comparison of real-time PCR probe designs on a model DNA plasmid. Anal. Biochem. 344 (2005) 257-265
28. Zimmerman S.B., and Harrison B. Macromolecular crowding accelerates the cohesion of DNA fragments with complementary termini. Nucleic Acids Res. 13 (1985) 2241-2249
29. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31 (2003) 3406-3415